![](/img/cover-not-exists.png)
A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors
Robert Chase, Angela Skelton, Ellen Xia, Stephanie Curry, Shaotang Liu, Patricia McMonagle, H.-C. Huang, Xiao TongVolume:
84
Year:
2009
Language:
english
Pages:
7
DOI:
10.1016/j.antiviral.2009.09.003
File:
PDF, 609 KB
english, 2009